Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression

Molecular and Cellular Biology

Volumn 30, Issue 12, 2010, Pages 3111-3125

  Yang, Chuanwei ^a   Chen, Li ^a   Li, Cuiqi ^a   Lynch, Mary C ^a   Brisken, Cathrin ^b   Schmidt, Emmett V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; CYCLIN D1; DNA; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; RNA;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST HYPERPLASIA; CANCER CELL; CANCER RISK; CONTROLLED STUDY; ENHANCER REGION; ESTROGEN THERAPY; GENE; HORMONE BINDING; HORMONE RESPONSE; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN D1; ENHANCER ELEMENTS, GENETIC; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; PROGESTERONE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS;

EID: 77953383265     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01398-09     Document Type: Article

References (52)

1. Aupperlee, M. D., K. T. Smith, A. Kariagina, and S. Z. Haslam. 2005. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 146: 3577-3588.
2. Bartek, J., J. Bartkova, and J. Taylor-Papadimitriou. 1990. Keratin 19 expression in the adult and developing human mammary gland. Histochem. J. 22:537-544. (Pubitemid 20349201)
3. Beatson, G. T. 1896. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet ii:104-107.
4. Bienvenu, F., S. Jirawatnotai, J. E. Elias, C. A. Meyer, K. Mizeracka, A. Marson, G. M. Frampton, M. F. Cole, D. T. Odom, J. Odajima, Y. Geng, A. Zagozdzon, M. Jecrois, R. A. Young, X. S. Liu, C. L. Cepko, S. P. Gygi, and P. Sicinski. 2010. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 463:374-378.
5. Carroll, J. S., X. S. Liu, A. S. Brodsky, W. Li, C. A. Meyer, A. J. Szary, J. Eeckhoute, W. Shao, E. V. Hestermann, T. R. Geistlinger, E. A. Fox, P. A. Silver, and M. Brown. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43.
6. Carroll, J. S., C. A. Meyer, J. Song, W. Li, T. R. Geistlinger, J. Eeckhoute, A. S. Brodsky, E. K. Keeton, K. C. Fertuck, G. F. Hall, Q. Wang, S. Bekiranov, V. Sementchenko, E. A. Fox, P. A. Silver, T. R. Gingeras, X. S. Liu, and M. Brown. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38:1289-1297.
7. Chlebowski, R. T., L. H. Kuller, R. L. Prentice, M. L. Stefanick, J. E. Manson, M. Gass, A. K. Aragaki, J. K. Ockene, D. S. Lane, G. E. Sarto, A. Rajkovic, R. Schenken, S. L. Hendrix, P. M. Ravdin, T. E. Rohan, S. Yasmeen, and G. Anderson. 2009. Breast cancer after use of estrogen plus progestin in postmenopausal women. N. Engl. J. Med. 360:573-587.
8. Daniel, A. R., M. Qiu, E. J. Faivre, J. H. Ostrander, A. Skildum, and C. A. Lange. 2007. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:188-201.
9. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
10. Driscoll, M. D., G. Sathya, M. Muyan, C. M. Klinge, R. Hilf, and R. A. Bambara. 1998. Sequence requirements for estrogen receptor binding to estrogen response elements. J. Biol. Chem. 273:29321-29330.
11. Feng, Y., D. Manka, K. U. Wagner, and S. A. Khan. 2007. Estrogen receptoralpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 104:14718-14723.
12. Groshong, S. D., G. I. Owen, B. Grimison, I. E. Schauer, M. C. Todd, T. A. Langan, R. A. Sclafani, C. A. Lange, and K. B. Horwitz. 1997. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol. Endocrinol. 11:1593-1607.
13. Halban, J. 1900. Ueber den Einfluss der Ovarien auf die Entwicklung des Genitales. Mschr. Geburtsh. Gynaek. 12:496-503.
14. Hall, J. M., and D. P. McDonnell. 1999. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566-5578.
15. Hinds, P. W., S. F. Dowdy, E. N. Eaton, A. Arnold, and R. A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. U. S. A. 91:709-713.
16. Hiremath, M., J. P. Lydon, and P. Cowin. 2007. The pattern of beta-catenin responsiveness within the mammary gland is regulated by progesterone receptor. Development 134:3703-3712.
17. Huggins, G. S., J. Y. Wong, S. E. Hankinson, and I. De Vivo. 2006. GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism. Cancer Res. 66:1384-1390.
18. Katti, M. V., M. K. Sakharkar, P. K. Ranjekar, and V. S. Gupta. 2000. TRES: comparative promoter sequence analysis. Bioinformatics 16:739-740.
19. Kester, H. A., B. M. van der Leede, P. T. van der Saag, and B. van der Burg. 1997. Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J. Biol. Chem. 272:16637-16643.
20. Kraus, W. L., M. M. Montano, and B. S. Katzenellenbogen. 1993. Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters. Mol. Endocrinol. 7:1603-1616.
21. Kuhn, R. M., D. Karolchik, A. S. Zweig, T. Wang, K. E. Smith, K. R. Rosenbloom, B. Rhead, B. J. Raney, A. Pohl, M. Pheasant, L. Meyer, F. Hsu, A. S. Hinrichs, R. A. Harte, B. Giardine, P. Fujita, M. Diekhans, T. Dreszer, H. Clawson, G. P. Barber, D. Haussler, and W. J. Kent. 2009. The UCSC Genome Browser database: update 2009. Nucleic Acids Res. 37:D755-D761.
22. Lammie, G. A., and G. Peters. 1991. Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3:413-420.
23. Landis, M. W., B. S. Pawlyk, T. Li, P. Sicinski, and P. W. Hinds. 2006. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9:13-22.
24. Lange, C. A. 2008. Challenges to defining a role for progesterone in breast cancer. Steroids 73:914-921.
25. Lupien, M., J. Eeckhoute, C. A. Meyer, Q. Wang, Y. Zhang, W. Li, J. S. Carroll, X. S. Liu, and M. Brown. 2008. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132:958-970.
26. Michaelson, J. S., and P. Leder. 2001. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20:5093-5099.
27. Motokura, T., T. Bloom, H. G. Kim, H. Juppner, J. V. Ruderman, H. M. Kronenberg, and A. Arnold. 1991. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512-515. (Pubitemid 21912266)
28. Mulac-Jericevic, B., J. P. Lydon, F. J. DeMayo, and O. M. Conneely. 2003. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U. S. A. 100:9744-9749.
29. Neuman, E., M. H. Ladha, N. Lin, T. M. Upton, S. J. Miller, J. DiRenzo, R. G. Pestell, P. W. Hinds, S. F. Dowdy, M. Brown, and M. E. Ewen. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17:5338-5347.
30. Offner, H., K. Adlard, A. Zamora, and A. A. Vandenbark. 2000. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 105:1465-1472.
31. O'Malley, B. W. 2005. A life-long search for the molecular pathways of steroid hormone action. Mol. Endocrinol. 19:1402-1411.
32. Otten, A. D., M. M. Sanders, and G. S. McKnight. 1988. The MMTV LTR promoter is induced by progesterone and dihydrotestosterone but not by estrogen. Mol. Endocrinol. 2:143-147.
33. Petz, L. N., and A. M. Nardulli. 2000. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol. Endocrinol. 14:972-985.
34. Poole, A. J., Y. Li, Y. Kim, S. C. Lin, W. H. Lee, and E. Y. Lee. 2006. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314:1467-1470.
35. Richer, J. K., B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz. 2002. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:5209-5218.
36. Rider, V., K. Isuzugawa, M. Twarog, S. Jones, B. Cameron, K. Imakawa, and J. Fang. 2006. Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells. J. Endocrinol. 191:537-548.
37. Said, T. K., O. M. Conneely, D. Medina, B. W. O'Malley, and J. P. Lydon. 1997. Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology 138:3933-3939.
38. Schultz, J. R., L. N. Petz, and A. M. Nardulli. 2005. Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors alpha and beta. J. Biol. Chem. 280:347-354.
39. Schultz, J. R., L. N. Petz, and A. M. Nardulli. 2003. Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression. Mol. Cell Endocrinol. 201:165-175.
40. Shi, H. Y., J. P. Lydon, and M. Zhang. 2004. Hormonal defect in maspin heterozygous mice reveals a role of progesterone in pubertal ductal development. Mol. Endocrinol. 18:2196-2207.
41. Shyamala, G., X. Yang, R. D. Cardiff, and E. Dale. 2000. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc. Natl. Acad. Sci. U. S. A. 97:3044-3049.
42. Shyamala, G., X. Yang, G. Silberstein, M. H. Barcellos-Hoff, and E. Dale. 1998. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc. Natl. Acad. Sci. U. S. A. 95:696-701.
43. Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
44. Sutherland, R. L., and E. A. Musgrove. 2004. Cyclins and breast cancer. J. Mammary Gland Biol. Neoplasia 9:95-104.
45. Sweeney, K. J., A. Swarbrick, R. L. Sutherland, and E. A. Musgrove. 1998. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene 16:2865-2878. (Pubitemid 28383271)
46. Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
47. Wilcken, N. R., O. W. Prall, E. A. Musgrove, and R. L. Sutherland. 1997. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Clin. Cancer Res. 3:849-854.
48. Yang, C., S. Trent, V. Ionescu-Tiba, L. Lan, T. Shioda, D. Sgroi, and E. V. Schmidt. 2006. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. Cancer Res. 66:11649-11658.
49. Yang, X., S. M. Edgerton, S. D. Kosanke, T. L. Mason, K. M. Alvarez, N. Liu, R. T. Chatterton, B. Liu, Q. Wang, A. Kim, S. Murthy, and A. D. Thor. 2003. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res. 63:2425-2433.
50. Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.
51. Zwijsen, R. M., R. S. Buckle, E. M. Hijmans, C. J. Loomans, and R. Bernards. 1998. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 12:3488-3498.
52. Zwijsen, R. M., E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, and R. J. Michalides. 1997. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415.